Background incidence rates of selected adverse events of special interest (AESI) to monitor the safety of COVID-19 vaccines.

ABSTRACT:

Background

Determining background rates of medical conditions identified as adverse events of special interest (AESI) that may occur following COVID-19 vaccination is important for contextualising and investigating potential vaccine safety signals.

Methods

We conducted a retrospective population-based cohort study using linked emergency department, hospitalisation and death data for 2017 and 2018 from Australia's most populous state, New South Wales. Incident cases of select neurological conditions, arterial or venous thromboembolic conditions, secondary thrombocytopenia, myocarditis/pericarditis, and unique events of anaphylaxis and generalised convulsions were identified using internationally agreed upon diagnostic (ICD-10) codes. State-specific rates per 100,000 person-ye

SUBMITTER: Pillsbury A 

PROVIDER: S-EPMC10110935 | biostudies-literature | 2023 May

REPOSITORIES: biostudies-literature